A phase I study to assess the safety, tolerability, and PK of ARRY-380, an oral HER2
|
All times are GMT -7. The time now is 09:12 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021